Company profile for BioStem Technologies

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BioStem Technologies, Inc. is a pre-clinical-stage biotechnology company focused on harnessing elements of Perinatal Tissue and the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Our proprietary approach, called Local MicroEnvironment Activation, or LMA, uses combinations of Small Molecules, Cytokines, and Growth Factors (“SMCGF”) to activate the microenvironment withi...
BioStem Technologies, Inc. is a pre-clinical-stage biotechnology company focused on harnessing elements of Perinatal Tissue and the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Our proprietary approach, called Local MicroEnvironment Activation, or LMA, uses combinations of Small Molecules, Cytokines, and Growth Factors (“SMCGF”) to activate the microenvironment within the body to create communication for repair in the tissue. Since our founding in 2014, we’ve pursued a singular goal: growing into an innovative life sciences company with the power to change lives for the better.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
2836 Center Port Circle Pompano Beach, FL 33064
Telephone
Telephone
(954) 380-8342
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/11/25/3194365/0/en/BioStem-Technologies-Expands-Product-Access-in-Medicaid.html

GLOBENEWSWIRE
25 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187812/0/en/BioStem-Technologies-Reports-Third-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/11/13/3187809/0/en/BioStem-Technologies-Announces-Filing-of-Restated-Financial-Statements.html

GLOBENEWSWIRE
13 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181920/0/en/BioStem-Technologies-Provides-Comments-on-CMS-CY-2026-Final-Medicare-Reimbursement-Rule-Changes-for-Skin-Substitutes.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181288/0/en/BioStem-Technologies-Secures-Land-Purchase-at-the-Research-Park-at-Florida-Atlantic-University-in-Boca-Raton-for-Future-Headquarters.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/10/31/3178220/0/en/BioStem-Technologies-Reports-Positive-Top-Line-Clinical-Results-Demonstrating-Superior-Outcomes-with-BioRetain-Allograft-in-Diabetic-Foot-Ulcers.html

GLOBENEWSWIRE
31 Oct 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty